Status:
COMPLETED
Effectiveness of Positioning on Back Pain After TACE Among Patients With HCC
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Liver Cancer
Transcatheter Arterial Chemoembolization
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Changing patients' position in the bed after TACE can decrease the level of back pain without increasing the amount of bleeding and hematoma,bring patients some comfort and relieving abdominal bloatin...
Detailed Description
Background：During the treatment for the liver cancer patients who are treated by Transcatheter Arterial Chemoembolization (TACE), the embolic agent with chemotherapeutic drugs are injected through a c...
Eligibility Criteria
Inclusion
- Patient with hepatocellular carcinoma hospitalized for TACE .
- Age ≧ 18.
- Consciousness can be communicated in Mandarin and Taiwanese.
Exclusion
- Symptoms of back pain before TACE.
- Under the treatment of analagesics within 24 hours before TACE.
- Anticoagulant was not discontinued for at least 7 days before TACE.
- Inguinal hemorrhage or hematoma during the TACE or before removal of the vascular sheath.
- Hemological diseases that are prone to bleeding, i.e. hemophilia and leukemia.
- Platelet count lower than 70K or INR (international normalized ratio) is greater than 1.4.
- No hemostatic cotton use.
- Can not change the position in bed after TACE.
Key Trial Info
Start Date :
February 21 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 28 2018
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03784469
Start Date
February 21 2018
End Date
August 28 2018
Last Update
October 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan